Molecular diagnostics system
1 conceptCepheid GeneXpert is a family of automated molecular diagnostic systems for PCR-based testing near the point of need.
A tighter look at the products that matter most to Danaher, along with the free, open, decentralized, or cooperative alternatives already creating pricing pressure and the original disruption concepts that could widen that pressure further.
Products
These pages zoom into the products and services that matter most to each company, the alternatives already nibbling at them, and 3 structured disruption concepts across the current product set.
Molecular diagnostics system
1 conceptCepheid GeneXpert is a family of automated molecular diagnostic systems for PCR-based testing near the point of need.
Bioprocessing equipment and consumables
2 conceptsCytiva provides bioprocessing technologies, systems, consumables, and services used to develop and manufacture biologic therapies.
Paper trail
These sources shaped the scoring and writing. The site is opinionated, but it should not behave like it is improvising facts in a dark room.
U.S. Securities and Exchange Commission · annual report
Primary annual financial and operating source for 2025 sales, profit, cash flow, assets, debt, equity, associates, and segment context.
Reviewed 2026-05-27
Danaher · investor relations
Primary investor-relations hub for company filings, results, and shareholder materials.
Reviewed 2026-05-27
StockAnalysis · market data
Late-May 2026 market-data source for market cap, P/E ratio, shares outstanding, price, and company profile summary.
Reviewed 2026-05-27
CompaniesMarketCap.com · market data
Registry-provided market-cap URL used as a cross-check for Danaher's public-company valuation.
Reviewed 2026-05-27